Skip to main content
SpringerLink
Log in

Striatum Adenosine A2 Receptors Are Modified During Seizure: Effect of Cyclopentyladenosine Administration

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Rat CNS adenosine A2A receptors were studied after administration of the convulsant drug 3-mercaptopropionic acid (MP) and the adenosine analogue cyclopentyladenosine (CPA) by means of a quantitative autoradiographic method. Specific binding was quantified in striatum only. The highest density was found in caudate-putamen (2.50 fmol/mm2), followed by nuclei accumbens (1.85 fmol/mm2) and the lowest values in the olfactory tubercle (1.26 fmol/mm2). These differerences were statiscally significant. MP administration (150 mg/kg) caused significant increases (12–18%) in caudate-putamen and nuclei accumbens in both stages: seizure and postseizure and no changes in the olfactory tubercle. CPA administration (2 mg/kg) originated a rise of 16% in nuclei accumbens but no change in the other two regions. When CPA was injected 30 minutes before MP, an increase (18 to 45%) in caudate-putamen and nuclei accumbens at seizure and postseizure stages was observed. Saturation results, in striatal membrane fraction, indicate that receptor sites increased their maximal binding capacity (Bmax) while the apparent dissociation constant (Kd) remained unchanged. These results suggest the involvement of the adenosine A2A receptors in convulsant activity and that CPA administration at the dose selected brings about a rise in neuronal excitability in this area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Miller, L. P., and Hsu, C. 1992. Therapeutic potential for adenosine receptor activation in ischemic brain injury. J. Neurotrauma, 9:S563-S577.

    Google Scholar 

  2. Williams, M. 1989. Adenosine: The prototypic neuromodulator. Neurochem. Int., 14:249–264.

    Google Scholar 

  3. Dunwiddie, T. V., and Worth, T. 1982. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J. Pharmacol., Exp. Therap. 220:70–76.

    Google Scholar 

  4. Young, D., and Dragunow, M. 1994. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience, 58:245–261.

    Google Scholar 

  5. Van Calker, D., Muller, M., and Hamprecht, B. 1979. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured cells. J. Neurochem., 33:999–1005.

    Google Scholar 

  6. Fredholm, B. B., Abracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., and Williams, M. 1994. VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46:143–155.

    Google Scholar 

  7. Olah, M. E., and Stiles, G. L. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Ann. Rev. Pharmacol. Toxicol., 35:581–606.

    Google Scholar 

  8. Bruns, R. F., Lu, G. H., and Pugsley, T. A. 1986. Characterization of the A2 adenosine receptor labeled by [3H]-NECA in rat striatal membranes. Mol. Pharmacol., 29:331–346.

    Google Scholar 

  9. Sebastiao, A. M., and Ribeiro, J. A. 1996. Adenosine A2 receptor-mediated excitatory actions on the nervous system. Progress in Neurobiology, 48:167–189.

    Google Scholar 

  10. Jarvis, M. F., Jackson, R. H., and Williams, M. 1989. Autoradiographic characterization of high-affinity adenosine A2 receptors in the rat brain. Brain Res., 484:111–118.

    Google Scholar 

  11. Rodríguez de Lores Arnaiz, G., Alberici de Canal, M., Robiolo, B., and Mistrorigo de Pacheco, M. 1973. The effect of the convulsant 3-mercaptopropionic acid on enzymes of the γ-amino-butyrate system in the rat cerebral cortex. J. Neurochem., 21:615–623.

    Google Scholar 

  12. Girardi, E., Perez Raffo, G., and Rodríguez de Lores Arnaiz, G. 1989a. Increase of 5′-nucleotidase activity in some brain subcellular fractions after the administration of the convulsant 3-mercaptopropionic acid. Neurochem. Int., 14:331–338.

    Google Scholar 

  13. Girardi, E., Perez Raffo, G., and Rodríguez de Lores Arnaiz, G. 1989b. A study of 5′-nucleotidase activity in subcellular fractions of rat cerebellum after the administration of the convulsant 3-mercaptopropionic acid. Mol. Chem. Neuropathol., 11:65–75.

    Google Scholar 

  14. Rodríguez de Lores Arnaiz, G., and Girardi, E. 1977. The increase in respiratory capacity of brain subcellular fractions after the administration of the convulsant 3-mercaptopropionic acid. Life Sci., 21:13–22.

    Google Scholar 

  15. Girardi, E., Schneider, P., and Rodríguez de Lores Arnaiz, G. 1994. Area-specific modification of acetylcholinesterase activity following 3-mercaptopropionic acid-induced seizures. Mol. Chem. Neuropathol., 21:13–22.

    Google Scholar 

  16. Rodríguez de Lores Arnaiz, G., Girardi, E., and Perez Raffo, G. 1993. Differential changes in CNS phosphatase activities during seizure. NeuroReport, 4:100–102.

    Google Scholar 

  17. Giraldez, L., Zanetti, F., and Girardi, E. 1995. [3H]-MK801 and [3H]-NECA binding change after the administration of cyclopentyladenosine and the convulsant drug 3-mercaptoproionic acid. Comm. Biol. (Bs. As.), 13:321–331.

    Google Scholar 

  18. Giraldez, L., Zanetti, F., Antonelli, M., Rodríguez de Lores Arnaiz, G., and Girardi, E. 1998. [3H]-CCPA binding to Adenosine A1 receptors is modified after the administration of 3-mercapto-propionic acid and cyclopentyladenosine. An autoradiographic study. Neurochem. Res., 23:175–181.

    Google Scholar 

  19. Giraldez, L., and Girardi, E. 1998. Modification of [3H]-MK801 binding to rat brain NMDA receptors after the administration of a convulsant drug and an adenosine analogue. A quantitative autoradiographic study. Neurochem. Res., 23:1327–1336.

    Google Scholar 

  20. Steele, R. J., Stewart, M. G., and Rose, S. P. R. 1995. Increase in NMDA receptors binding are specifically related to memory formation for a passive avoidance task in the chick: a quantitative autoradiographic study. Brain Res., 674:352–356.

    Google Scholar 

  21. Paxinox, G., and Watson, C. 1986. The Rat Brain in Stereotaxic Coordinates. (2nd ed.) Academic Press, New York.

    Google Scholar 

  22. Schiffmann, S. N., Libert, F., Vassart, G., and Vanderhaeghen, J. J. 1991. Distribution of adenosine A2 receptor mRNA in the human brain. Neuroscience Lett., 130:177–181.

    Google Scholar 

  23. Schiffmann, S. N., and Vanderhaeghen, J. J. 1992. Ontogeny of gene expression of adenosine A2 receptor in the striatum: early localization in the patch copartment. J. Comp. Neurol., 317:117–128.

    Google Scholar 

  24. Jarvis, M. F. 1991. Autoradiographic localization and characterization of adenosine receptor subtypes in mammalian brain. Nucleosides & Nucleotides, 10:993–1001.

    Google Scholar 

  25. Jarvis, M. F., and Williams, M. 1989. Direct autoradiographic localization of A2 adenosine receptors in the rat brain using the A2-selective agonist [3H]-CGS21680. Eur. J. Pharmacol., 168:243–246.

    Google Scholar 

  26. Parkinson, F. E., and Fredholm, B. B. 1992. Magnesium-dependent enhancement of endogenous agonist binding to adenosine A1 receptors: a complicating factor in quantitative-autoradiography. J. Neurochem., 58:941–950.

    Google Scholar 

  27. Fredholm, B. B., Lindström, K., Ionisotti S., and Ongini, E. 1998. [3H]-SCH58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies. 70:1210–1216.

    Google Scholar 

  28. Latini, S., Pazzagli, M., Pepeu, G., and Pedata, F. 1996. A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen. Pharmac., 27:925–933.

    Google Scholar 

  29. Ongini, E., Adami, M., Ferri, C., Bertorelli, R. 1997. Adenosine A2A receptors and neuroprotection. Ann. NY Acad. Sci., 15:825:30–48.

    Google Scholar 

  30. Simpson, R. E., O'Regan, M. H., Perkins, L. M., and Phillis, J. W. 1992. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J. Neurochem., 58:1683–1690.

    Google Scholar 

  31. Yoneda, Y., and Ogita, K. 1991. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques. J. Pharmacol. Exp. Ther., 259: 86–96.

    Google Scholar 

  32. Cunha, R. A., Johansson, B., van der Ploeg, Y., Sebastiao A. M., Ribeiro, J. A., and Fredholm, B. B. 1994. Evidence for functionally important adenosine A2A receptors in the rat hippocampus. Brain Res., 649:208–216.

    Google Scholar 

  33. Rodríguez de Lores Arnaiz, G., Alberici de Canal, M., and De Robertis, E. 1972. Alteration of GABA system and Purkinje cells in rat cerebellum by the convulsant 3-mercaptopropionic acid. J. Neurochem., 19:1379–1385.

    Google Scholar 

  34. Mayfield, R. D., Suzuki, F., and Zahniser, N. R. 1993. Adenosine A2A receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J. Neurochem., 60:2334–2337.

    Google Scholar 

  35. Ferré, S., Fuxe, K., von Euler, G., Johansson, B., and Fredholm, B. B. 1992. Adenosine-dopamine interactions in the brain. Neuroscience, 51:501–512.

    Google Scholar 

  36. Ferré, S., Fredholm, B. B., Morelli, M., Popoli, P., and Fuxe, K. 1997. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. TINS, 20: 482–487.

    Google Scholar 

  37. Kenakin, T. 1993. Stimulus-Response mechanisms. Pages 39–68, in Kenakin, T. (2nd Ed.), Pharmacologic analysis of drug-receptor interaction. Raven Press, New York.

    Google Scholar 

  38. Rodríguez de Lores Arnaiz, G., Alberici de Canal, M., and De Robertis, E. 1972. Alteration of GABA system and Purkinje cells in rats cerebellum by the convulsant 3-mercaproprionic acid. J. Neurochem., 19:1379–1385.

    Google Scholar 

  39. Johansson, B., Georgiev, V., Parkinson, F. E., and Fredholm, B. B. 1993. The binding of the adenosine A2 receptor selective agonist [3H]-CGS21680 to rat cortex differs from its binding to rat striatum. Eu. J. Pharmacol. Mol. Pharmacol Sec., 247:103–110.

    Google Scholar 

  40. Daval, J. L., Nicolas, F., and Doriat, J. F. 1996. Adenosine physiology and pharmacology: how about A2 receptors? Pharmacol. Ther., 71:325–335.

    Google Scholar 

  41. Daval, J. L. Nehlig, A., and Nicolas, F. 1991. Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci., 49:1435–1453.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Biología Celular y de Neurociencia “Prof Eduardo De Robertis”, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina

    Lisandro Giraldez, Flavia Zanetti & Elena Girardi

Authors
  1. Lisandro Giraldez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Flavia Zanetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Girardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Girardi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giraldez, L., Zanetti, F. & Girardi, E. Striatum Adenosine A2 Receptors Are Modified During Seizure: Effect of Cyclopentyladenosine Administration. Neurochem Res 24, 1217–1223 (1999). https://doi.org/10.1023/A:1020964721242

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020964721242

Search

Navigation